ACM
TIL icon

ADAR1 Capital Management’s Instil Bio TIL Stock Holding History

ADAR1 Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,328
Closed -$422K – 236
2025
Q1 		$422K Sell
24,328
-7,380
-23% -$153K 0.08% 116
2024
Q4 		$605K Buy
31,708
+8,001
+34% +$244K 0.12% 105
2024
Q3 		$1.6M Buy
+23,707
New +$558K 0.26% 57

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

ADAR1 Capital Management's TIL Position: Q2 2025 in Review

ADAR1 Capital Management sold out of Instil Bio (TIL) in Q2 2025, closing a stake of 24,328 shares — an estimated $422K sold.

ADAR1 Capital Management first reported a position in TIL in Q3 2024 and held it in 3 quarters. The position peaked at $1.6M in Q3 2024. 38 funds tracked by Wall St. Rank hold TIL as of Q2 2025.

  • ADAR1 Capital Management reported no remaining Instil Bio position as of Q2 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 24,328 Instil Bio shares in Q2 2025, an estimated $422K.
  • ADAR1 Capital Management first reported a position in Instil Bio in Q3 2024 and held it in 3 quarters.
  • ADAR1 Capital Management's Instil Bio position peaked at $1.6M in Q3 2024.
  • 38 funds tracked by Wall St. Rank held Instil Bio as of Q2 2025.

Based on ADAR1 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.